The global automated breast ultrasound systems (ABUS) market is set to experience substantial growth, with an estimated valuation of USD 1.95 billion in 2023, projected to surge to USD 7.23 billion by 2033. This robust expansion corresponds to a compound annual growth rate (CAGR) of 14% during the forecast period, underscoring the rising demand for advanced breast imaging technologies.
ABUS technology has emerged as a critical tool in the early detection of breast cancer, particularly in women with dense breast tissue where traditional mammography may be less effective. Automated systems enhance accuracy, reduce operator dependency, and provide comprehensive 3D imaging, significantly improving diagnostic outcomes.
The growing prevalence of breast cancer globally, coupled with increasing awareness about the benefits of early detection, is driving market adoption. Healthcare providers are increasingly integrating ABUS into routine breast cancer screening protocols, paving the way for better patient care and early intervention strategies.
Key Takeaways:
- Market Growth: Valued at USD 1.95 billion in 2023, projected to reach USD 7.23 billion by 2033, with a CAGR of 14%.
- Advancements in Detection: ABUS technology provides superior imaging, especially for dense breast tissue, compared to traditional methods.
- Global Health Impact: Rising breast cancer incidence emphasizes the need for advanced screening tools.
- Expanding Adoption: Increasing integration of ABUS in healthcare facilities highlights its role in improving diagnostic accuracy and outcomes.
A Comprehensive Full Report – https://www.futuremarketinsights.com/reports/automated-breast-ultrasound-system-market
Factors Driving Market Growth
- Increasing Prevalence of Breast Cancer: The rising incidence of breast cancer globally is a significant factor driving demand for automated breast ultrasound systems, which provide enhanced imaging capabilities for early detection.
- Advancements in Technology: Automated breast ultrasound systems offer superior imaging compared to traditional methods, particularly for patients with dense breast tissue, improving diagnostic accuracy.
- Growing Awareness of Early Detection: There is an increasing emphasis on the importance of early detection of breast cancer, leading to greater adoption of advanced screening technologies.
- Patient Comfort and Efficiency: These systems are designed to be user-friendly and provide efficient screening processes, enhancing patient comfort and throughput in healthcare settings.
- Supportive Healthcare Policies: Government initiatives and funding aimed at improving cancer screening programs are facilitating market growth.
Automated Breast Ultrasound Systems – Competitive Landscape
Key market players in the automated breast ultrasound system market are focusing on installing ABUS in hospitals and diagnostics centers to expand their global footprint. They are also working towards developing the accuracy of automated breast ultrasound systems for faster cancer screening assessment and getting government approval for their products.
Key players are investing heavily in research and development activities to develop essential and improved products. These players are adopting various market methodologies such as mergers, acquisitions, product launches, collaborations, and partnerships. They are distributing their products with local and international suppliers to reach relevant audiences to increase sales volume.
Other Essential Players in the Global Market are:
- GE Healthcare
- Hitachi Ltd
- SonoCine Inc
- Philips Healthcare
- Siemens Healthineers
- Supersonic Imagine
- Toshiba Corporation
- QT Ultrasound LLC
- Adaltis S.r.l.
- Volpara Health Technologies
- Delphinus Medical Technologies, Inc
- General Electric Company
- Hologic, Inc
- Telemed Systems, Inc
Recent Developments in the Global Market are:
- Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring images of the complete breast.
- Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.
- Siemens Healthineers AG introduced a new automated breast ultrasound system “ACUSON S2000 ABVS” as a part of its imaging, diagnostics segment with a 3D imaging feature required to find the lesions in fatty and dense breast tissue.
Automated breast ultrasound system named “AWBUS” made by SonoCiné is capable of providing repeated scans of the whole breast with the same consistency and accuracy necessary for the accurate detection of cancer.
Key Companies Profiled
GE Healthcare; Hitachi Ltd; SonoCine Inc; Philips Healthcare; Siemens Healthineers; Supersonic Imagine; Toshiba Corporation; QT Ultrasound LLC; Adaltis S.r.l.; Volpara Health Technologies; Delphinus Medical Technologies, Inc; General Electric Company; Hologic, Inc; Telemed Systems, Inc
Automated Breast Ultrasound Systems Market by Category
By End User:
- Hospitals
- Diagnostic Imaging Laboratories
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
